| Literature DB >> 35323277 |
Tina Sabel-Grau1, Arina Tyushina1, Cigdem Babalik1, Marga C Lensen1.
Abstract
Multifunctional biomedical materials capable of integrating optical functions are highly desirable for many applications, such as advanced intra-ocular lens (IOL) implants. Therefore, poly(ethylene glycol)-diacrylate (PEG-DA) hydrogels are used with different photoinitiators (PI). In addition to standard UV PI Irgacure, Erythrosin B and Eosin Y are used as PI with high sensitivity in the optical range of the spectrum. The minimum PI concentrations for producing new hydrogels with PEG-DA and different PIs were determined. Hydrogel films were obtained, which were applicable for light-based patterning and, hence, the functionalization of surface and volume. Cytotoxicity tests confirm cytocompatibility of hydrogels and compositions. Exploiting the correlation of structure and function allows biomedical materials with multifunctionality.Entities:
Keywords: hydrogels; light-responsive materials; multifunctional biomedical biomaterials; photo curing; photopolymers; volume holography
Year: 2022 PMID: 35323277 PMCID: PMC8956119 DOI: 10.3390/gels8030164
Source DB: PubMed Journal: Gels ISSN: 2310-2861
Minimum PI concentration to make gel for the different PIs.
| Photoinitiator (PI) | Minimum PI Concentration to Make Gel with PEG-DA |
|---|---|
| Irgacure 2959 | 0.025% |
| EB | 0.1% |
| EY | 0.5% |
Figure 1UV-Vis spectra for the novel PIs (EB and EY) with PEG-DA before and after crosslinking, respectively. The hydrogels with new PIs (EB and EY) feature good spectroscopic properties, allowing for use with light sources in the visible range.
Figure 2Fluorescent images of cells test by live/dead cell assay with L929 after incubated for 24 h. (a) Control cells; (b) EB; (c) EY; (d) EB 0.1% with PEG-DA; (e) optical micrograph of cross-linked EB/PEG-DA hydrogel; (f) fluorescence image of cross-linked EB/PEG-DA hydrogel. Scale bar depicts 50 µm.
Figure 3Irgacure 2959, Erythrosin B and Eosin Y are used as photoinitiators (PI); PEG-DA as a precursor for PEG hydrogel.